Mediar Therapeutics Enters into Global Licensing Agreement with Lilly to Advance First-in-Class WISP1 Antibody for the Treatment of Idiopathic Pulmonary Fibrosis (IPF)January 10, 2025
Spectral Capital Welcomes Aaron Christensen as Chief Revenue Officer to Lead Global Expansion of Vogon Cloud SolutionsJanuary 10, 2025
Purdue Global leader’s projects support student success, earned credits, achievement and graduationJanuary 10, 2025
By 
